HEMATOLOGY Journal
                Print ISSN: 1024-5332 
Online ISSN: 1607-8454
Journal Impact Factor: 2.269
The official Journal of the International Society of Hematology (ISH) 
https://www.tandfonline.com/toc/yhem20/current
HEMATOLOGY is provided with online access to all ISH Members .
    
        
            | HEMATOLOGY is an international journal publishing original and review articles in the field of general hematology, oncology, pathology, biology, clinical research and epidemiology. Annotations are accepted on any general or scientific field: technical notes covering current laboratory practice in hematology, blood transfusion and clinical trials, and current clinical practice reviews the consensus driven areas of patient care and management. HEMATOLOGY aims to bridge the interests and practices of both those carrying out laboratory work and those whose main inclination is towards patient care. The Journal provides a forum where the clinical aspects of any published material will be emphasized.The editors welcome papers from all related areas of research including:
 
                General hematologyOncology Pathology Biology Clinical research Epidemiology Thalassemias and leukemias |   | 
    
Frequency 
From 2015, HEMATOLOGY will be published 10 issues per year.
Editor's Choice articles updated for 2015
Professor Adrian Newland has now chosen 10 new articles to feature as 'Editor's Choice' articles in 2015. The articles are chosen to demonstrate the breadth, quality and topical content of the journal. All of these articles are completely free to download. Follow the links on the right-hand side of the page.
HEMATOLOGY 
Editor-in-Chief:
Co-editors:
Associate Editors:
    
    - Prof Sule Unal Cangul       (Hacettepe University, Ankara, Turkey)
- Dr Nicholas Francis       Grigoropoulos (Singapore General Hospital, Singapore)
- Dr Andrés Gómez-De León       (Universidad Autónoma de Nuevo León, Mexico)
- Dr Azlan Husin (Universiti       Sains Malaysia, Malaysia)
- Dr Dennis Kim (Princess       Margaret Cancer Centre, Ontario, Canada)
- Dr Peter MacCallum (Royal       London Hospital, London, UK)
- Dr Roberta Russo       (University of Naples Federico II, Naples, Italy)
- Dr Mark Yazer (University       of Pittsburgh, PA, USA)
Editorial Board:
    - Dr Hanny Al-Samkari       (Massachusetts General Hospital, Harvard Medical School, USA)
- Dr Prithviraj Bose       (Department of Leukemia, The University of Texas, USA)
- Dr Jim Bussel (Department       of Pediatrics, New York-Presbyterian Hospital, NY, USA)
- Professor James CS Chim       (Division of Haematology, Queen Mary Hospital, University of Hong Kong,       Hong Kong)
- Dr Soon-Keng Cheong       (Department of Haematology, Hospital Universiti Kebangsaan Malaysia)
- Dr David Gomez-Almaguer       (University Hospital UANL, Mexico)
- Dr Achille Iolascon       (Department of Medical Genetics, Federico II University, Naples, Italy)
- Professor Saengsuree Jootar       (Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand)
- Dr Harinder Juneja       (University of Texas Health Science Center at Houston, TX, USA)
- Professor Emin Kansu       (Hacettepe University Institute of Oncology, Turkey)
- Dr Kevin Kuo (Toronto       General Hospital, Ontario, Canada)
- Professor Lucio Luzzatto       (Muhimbili University, Tanzania)
- Dr Lucia Masarova (MD       Anderson Cancer Center, Houston TX, USA)
- Dr Ruben A Mesa (Division       of Hematology & Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA)
- Dr Anthony Mills (Princess       Alexandra Hospital, Australia)
- Professor Tomoki Naoe       (Department of Hematology and Oncology, Nagoya University Graduate School       of Medicine, Japan)
- Dr Kazuma Ohyashiki (Tokyo       Medical University, Japan)
- Dr Maro Ohanian (MD       Anderson Cancer Center, Houston TX, USA)
- Dr Guillermo J.       Ruiz-Arguelles (Centro de Hematología y Medicina Interna, Clínica Ruiz,       Mexico)
- Dr Martin Tallman       (Northwestern University Medical School, Chicago, IL, USA)
- Professor Jianxiang Wang       (Institute of Hematology & Hospital of Blood Disease, Peking Union       Medical College, Tianjin, China)
- Dr Musa Yilmaz (MD Anderson       Cancer Center, Houston TX, USA)